TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | NAN |
| S | %wins | 100 | 100 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/10/17 16:30 | 5/8/17 | OXFD | Oxford Immunotec Global Plc | X0 | Health | Diagn | In Vitro & In Vivo Diagnostic | Schroeder Jeff R. | X0 | O | Chief Co | S.m | -566 | 14.14 | 2 | -40 | -24 | 127 | D | 14 | 40 | 4 | 9 | -6 | -6 | -6 | 2 | 0 | |||||
5/10/17 16:30 | 5/8/17 | OXFD | Oxford Immunotec Global Plc | X0 | Health | Diagn | In Vitro & In Vivo Diagnostic | Schroeder Jeff R. | X0 | O | Chief Co | S.m | -566 | 14.14 | 2 | -40 | -24 | 127 | D | 14 | 40 | 4 | 9 | -6 | -6 | -6 | 2 | 0 | |||||
4/5/17 16:30 | 4/4/17 | OXFD | Oxford Immunotec Global Plc | X0 | Health | Diagn | In Vitro & In Vivo Diagnostic | Schroeder Jeff R. | X0 | O | Chief Co | M.d | 6 | 0.0900 | 2 | 65 | 64 | 167 | D | 18 | 42 | 19 | 4 | 15 | 2 | -1 | -1 | 0 | 1 | -7 | |||
1/4/17 16:30 | 1/3/17 | OXFD | Oxford Immunotec Global Plc | X0 | Health | Diagn | In Vitro & In Vivo Diagnostic | Schroeder Jeff R. | X0 | O | Chief Co | M.d | 3 | 0.0900 | 1 | 36 | 63 | 93 | D | 8 | 35 | 66 | 15 | 1 | -2 | -1 | 0 | -1 | -2 | -10 | 3 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |